Literature DB >> 17076266

Misregulation of tau alternative splicing in neurodegeneration and dementia.

Athena Andreadis1.   

Abstract

Tau is a microtubule-associated protein that fulfills several functions critical for neuronal formation and health. Tau discharges its functions by producing multiple isoforms via intricately regulated alternative splicing. These isoforms modulate tau function in normal brain by altering the domains of the protein, thereby influencing its conformation and post-translational modifications and hence its affinity for microtubules and other ligands. Disturbances in tau expression result in disruption of the neuronal cytoskeleton and formation of pathological tau structures (neurofibrillary tangles) found in brains of dementia sufferers. More specifically, aberrations in tau splicing regulation directly cause several neurodegenerative diseases that lead to dementia. This review briefly presents our cumulative knowledge of tau splicing regulation in connection with the alterations in tau splicing seen in neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17076266     DOI: 10.1007/978-3-540-34449-0_5

Source DB:  PubMed          Journal:  Prog Mol Subcell Biol        ISSN: 0079-6484


  26 in total

1.  Differential regulation of dynein and kinesin motor proteins by tau.

Authors:  Ram Dixit; Jennifer L Ross; Yale E Goldman; Erika L F Holzbaur
Journal:  Science       Date:  2008-01-17       Impact factor: 47.728

2.  PSF suppresses tau exon 10 inclusion by interacting with a stem-loop structure downstream of exon 10.

Authors:  Payal Ray; Amar Kar; Kazuo Fushimi; Necat Havlioglu; Xiaoping Chen; Jane Y Wu
Journal:  J Mol Neurosci       Date:  2011-09-01       Impact factor: 3.444

Review 3.  Tau splicing and the intricacies of dementia.

Authors:  Athena Andreadis
Journal:  J Cell Physiol       Date:  2012-03       Impact factor: 6.384

4.  RNA helicase p68 (DDX5) regulates tau exon 10 splicing by modulating a stem-loop structure at the 5' splice site.

Authors:  Amar Kar; Kazuo Fushimi; Xiaohong Zhou; Payal Ray; Chen Shi; Xiaoping Chen; Zhiren Liu; She Chen; Jane Y Wu
Journal:  Mol Cell Biol       Date:  2011-02-22       Impact factor: 4.272

Review 5.  Biochemistry and cell biology of tau protein in neurofibrillary degeneration.

Authors:  Eva-Maria Mandelkow; Eckhard Mandelkow
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

Review 6.  Roles of tau protein in health and disease.

Authors:  Tong Guo; Wendy Noble; Diane P Hanger
Journal:  Acta Neuropathol       Date:  2017-04-06       Impact factor: 17.088

Review 7.  Alternative splicing and disease.

Authors:  Jamal Tazi; Nadia Bakkour; Stefan Stamm
Journal:  Biochim Biophys Acta       Date:  2008-10-17

Review 8.  Tau in physiology and pathology.

Authors:  Yipeng Wang; Eckhard Mandelkow
Journal:  Nat Rev Neurosci       Date:  2015-12-03       Impact factor: 34.870

Review 9.  Antisense oligonucleotides: the next frontier for treatment of neurological disorders.

Authors:  Carlo Rinaldi; Matthew J A Wood
Journal:  Nat Rev Neurol       Date:  2017-12-01       Impact factor: 42.937

10.  Heterogeneous nuclear ribonucleoprotein E3 modestly activates splicing of tau exon 10 via its proximal downstream intron, a hotspot for frontotemporal dementia mutations.

Authors:  Yan Wang; Lei Gao; Sze-Wah Tse; Athena Andreadis
Journal:  Gene       Date:  2009-11-12       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.